PWUPU · Powerup Acquisition Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.4K | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $22.6K | - | $1.1K | - | - | - | - | - | - | - |
| Gross Profit | $5.8K | - | $884 | - | - | - | - | - | - | - |
| R&D | $296.7K | - | $207.9K | $352.9K | $10.5K | - | - | - | - | - |
| SG&A | $1.02M | - | $513.0K | $395.7K | $15.07M | - | $630.8K | $501.0K | $2.52M | - |
| Total Operating Expenses | $1.65M | - | $1.15M | $799.9K | $15.56M | - | $630.8K | $501.0K | $2.52M | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($15.56M) | - | ($215.3K) | - | - | - | - | - | - | - |
| Interest Expense | $289.9K | - | $1.48M | $527.9K | $289.9K | - | - | - | $183.3K | - |
| Income Tax | - | - | $1.0K | - | - | - | - | - | - | - |
| Net Income | ($3.22M) | - | ($1.85M) | ($1.98M) | ($15.94M) | - | ($537.0K) | ($602.3K) | ($2.47M) | - |
| EPS - Basic | ($20.57) | - | ($0.01) | - | - | - | - | - | - | - |
| EPS - Diluted | ($504.88) | - | ($0.01) | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.00M | $1.00M | $1.95M | $206.2K | $47.3K | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $370.0K | $253.2K | $35.4K | - | - | - | - | - | - | - |
| Accounts Payable | $857.9K | $1.01M | $1.06M | $1.35M | $1.43M | - | - | - | - | - |
| Current Assets | $7.12M | $1.31M | $2.40M | $989.4K | $1.97M | $45.8K | $61.8K | $343.0K | $65.6K | $81.2K |
| Total Assets | $7.12M | $1.31M | $2.40M | $989.4K | $1.97M | $6.71M | $6.66M | $6.87M | $20.20M | $19.98M |
| Current Liabilities | $3.15M | $7.59M | $13.86M | $10.56M | $8.87M | $15.62M | $6.57M | $6.24M | $2.63M | $403.3K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $3.25M | $7.69M | $13.87M | $10.61M | $8.92M | $15.62M | $6.57M | $6.24M | $2.63M | $403.3K |
| Stockholders' Equity | $3.87M | ($6.38M) | ($11.47M) | ($9.62M) | ($6.95M) | ($15.57M) | ($6.51M) | ($5.90M) | ($2.57M) | ($322.1K) |
| Retained Earnings | ($30.48M) | ($27.26M) | ($22.55M) | ($20.70M) | ($18.72M) | ($24.37M) | ($15.38M) | ($14.76M) | ($13.99M) | ($11.29M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($3.04M) | - | - | - | ($1.75M) | - | - | - | ($2.26M) | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | $7.89M | - | - | - | $3.09M | - | - | - | $2.26M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 20.3% | - | - | - | - | - | - | - | - | - |
| Operating margin | -54867.1% | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | -11367.0% | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 1046.5% | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 3599.1% | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -45.3% | - | -77.0% | -200.2% | -811.1% | - | -8.1% | -8.8% | -12.2% | - |
| Return on equity | -83.3% | - | 16.1% | 20.6% | 229.3% | - | 8.2% | 10.2% | 96.1% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.26 | 0.17 | 0.17 | 0.09 | 0.22 | 0.00 | 0.01 | 0.05 | 0.02 | 0.20 |
| Quick ratio | 2.14 | 0.14 | 0.17 | 0.09 | 0.22 | 0.00 | 0.01 | 0.05 | 0.02 | 0.20 |
| Cash ratio | 0.32 | 0.13 | 0.14 | 0.02 | 0.01 | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -53.7x | - | -0.1x | - | - | - | - | - | - | - |
| Equity multiplier | 1.84 | -0.21 | -0.21 | -0.10 | -0.28 | -0.43 | -1.02 | -1.16 | -7.87 | -62.04 |
| Liabilities / Assets | 0.46 | 5.86 | 5.77 | 10.72 | 4.54 | 2.33 | 0.99 | 0.91 | 0.13 | 0.02 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | - | - | - | - | - | - | - | - | - |
| Inventory turnover | 0.06 | - | 0.03 | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 5974d | - | 12237d | - | - | - | - | - | - | - |
| Days payable outstanding | 13854d | - | 366343d | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | 79.8% | - | -244.6% | -229.0% | -546.2% | - | -675.4% | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | 59.0% | -76.1% | -63.1% | -170.8% | -4733.9% | -10242.6% | - | 75.0% | 96.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Geographic
$6.2K totalUS$6.2K · 99.2%
CA$30 · 0.5%
GB$19 · 0.3%
Peer comparison
Same SIC group: Pharmaceutical Preparations
Comparing PowerUp Acquisition Corp. against the 5 most active filers in the same SIC group.